Impact of pegylated interferon therapy on outcomes of patients with hepatitis C virus-related hepatocellular carcinoma after curative hepatic resection

Annals of Surgical Oncology

Volumn 19, Issue 2, 2012, Pages 418-425

  Tanimoto, Yoshisato ^a   Tashiro, Hirotaka ^a   Aikata, Hiroshi ^a   Amano, Hironobu ^a   Oshita, Akihiko ^a   Kobayashi, Tsuyoshi ^a   Kuroda, Shintaro ^a   Tazawa, Hirofumi ^a   Takahashi, Shoichi ^a   Itamoto, Toshiyuki ^b   Chayama, Kazuaki ^a   Ohdan, Hideki ^a  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^b Hiroshima Prefecture Hiroshima Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE PERIOD;

AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATECTOMY; HEPATITIS C; HUMANS; INTERFERON-ALPHA; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POLYETHYLENE GLYCOLS; PROGNOSIS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84856676800     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1866-1     Document Type: Article

References (38)

1. RTP Poon ST Fan CM Lo CL Liu J Wong 1999 Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors Ann Surg. 229 216 222 10024103 10.1097/00000658- 199902000-00009 1:STN:280:DyaK1M7ks1Ojug%3D%3D
2. M Minagawa M Makuuchi T Takayama N Kokudo 2003 Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma Ann Surg. 238 703 710 14578733 10.1097/01.sla.0000094549.11754.e6
3. T Itamoto H Nakahara H Amano, et al. 2007 Repeat hepatectomy for recurrent hepatocellular carcinoma Surgery. 141 589 597 17462458 10.1016/j.surg.2006.12.014
4. K Ikeda S Saitoh Y Arase K Chayama, et al. 1999 Effects of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1, 643 patients using statistical bias correction with proportional hazard analysis Hepatology. 29 1124 1130 10094956 10.1002/hep.510290439 1:CAS:528:DyaK1MXisVKgsLk%3D
5. Y Imai S Kawata S Tamura, et al. 1998 Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group Ann Intern Med. 129 94 99 9669992 1:CAS:528:DyaK1cXlt1emsbk%3D
6. C Camma M Giunta P Andreone A Craxì 2001 Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach J Hepatol. 34 593 602 11394661 10.1016/S0168-8278(01)00005-8 1:CAS:528: DC%2BD3MXjvVerur4%3D
7. S Nishiguchi S Shiomi S Nakatani, et al. 2001 Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis Lancet. 357 196 197 11213099 10.1016/S0140-6736(00)03595-9 1:STN:280:DC%2BD3M7kvFCitQ%3D%3D
8. Y Tomimaru H Nagano H Eguchi, et al. 2010 Effects of preceding interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma J Surg Oncol. 102 308 314 20589711 10.1002/jso.21633 1:CAS:528:DC%2BC3cXht1WjsrfP
9. SC Jeong H Aikata Y Katamura, et al. 2007 Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma World J Gastroenterol. 13 5188 5195 17876889 1:CAS:528:DC%2BD2sXht1emtbzL
10. SC Jeong H Aikata Y Kayamura, et al. 2007 Effects of a 24-week course of interferon-α therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma World J Gastroenterol. 13 5343 5350 17879404
11. H Harada M Kitagawa N Tanaka, et al. 1993 Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 Science. 259 971 974 8438157 10.1126/science.8438157 1:CAS:528:DyaK3sXhsVGkurk%3D
12. C Liedtke N Grogner MP Manns C Trautwein 2006 Interferon-alpha enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells J Hepatol. 44 342 349 16225956 10.1016/j.jhep.2005.07.020 1:CAS:528:DC%2BD28Xktl2quw%3D%3D
13. S Kubo S Nishiguchi K Hirohashi H Tanaka T Shuto H Kinoshita 2002 Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy Br J Surg. 89 418 422 11952580 10.1046/j.0007-1323.2001.02054.x 1:STN:280: DC%2BD383hs1KrtQ%3D%3D
14. K Ikeda Y Arase S Saitoh, et al. 2000 Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of primary tumor-a prospective randomized study of hepatitis C virus-related liver cancer Hepatology. 32 228 232 10915728 10.1053/jhep.2000.9409 1:CAS:528: DC%2BD3cXlvVyjtrk%3D
15. V Mazzaferro R Romito M Schiavo, et al. 2006 Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis Hepatology. 44 1543 1554 17133492 10.1002/hep.21415 1:CAS:528:DC%2BD2sXislKktQ%3D%3D
16. CM Lo CL Liu SC Chan, et al. 2007 A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma Ann Surg. 245 831 842 17522506 10.1097/01.sla.0000245829.00977.45
17. MP Manns JG McHutchison SC Gordon, et al. 2001 Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial Lancet. 358 958 965 11583749 10.1016/S0140-6736(01)06102-5 1:CAS:528:DC%2BD3MXntF2qtb8%3D
18. MW Fried ML Shiffman K Rajender Reddy, et al. 2002 Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med. 347 975 982 12324553 10.1056/NEJMoa020047 1:CAS:528:DC%2BD38Xnt12rtb0%3D
19. H Yoshida Y Arakawa M Sata, et al. 2002 Interferon therapy prolonged life expectancy among chronic hepatitis C patients Gastroenterology. 123 483 491 12145802 10.1053/gast.2002.34785 1:CAS:528:DC%2BD38XmsFahtL8%3D
20. K Kiyosawa T Uemura T Ichijo, et al. 2004 Hepatocellular carcinoma: recent trends in Japan Gastroenterology. 127 S17 S26 15508082 10.1053/j.gastro.2004.09.012
21. JG McHutchison SC Gordon ER Schiff, et al. 1998 Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group N Engl J Med. 339 1485 1492 9819446 10.1056/NEJM199811193392101 1:CAS:528:DyaK1cXnslGmtbs%3D
22. AJ Muir JD Bornstein PG Killenberg 2004 Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites N Eng J Med. 350 2265 2271 10.1056/NEJMoa032502 1:CAS:528: DC%2BD2cXksVehtr4%3D
23. H Shirakawa A Matsumoto S Joshita, et al. 2008 Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis c patients using viral and host factors Hepatology. 48 1753 1760 18925643 10.1002/hep.22543 1:CAS:528:DC%2BD1cXhsFamsrbF
24. T Kogure Y Ueno K Fukushima, et al. 2008 Pegylated interferon plus ribavirin for genotype 1b chronic hepatitis C in Japan World J Gastroentrol. 14 7225 7230 10.3748/wjg.14.7225 1:CAS:528:DC%2BD1MXjslKlsb4%3D
25. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 5th ed. Tokyo: Kanehara; 2008.
26. T Itamoto H Nakahara H Tashiro, et al. 2005 Indications of partial hepatectomy for transplantable hepatocellular carcinoma with compensated cirrhosis Am J Surg. 189 167 172 15720984 10.1016/j.amjsurg.2004.11.001
27. K Oishi T Itamoto T Kobayashi, et al. 2009 Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more J Gastrointest Surg. 13 695 701 19050982 10.1007/s11605-008-0758-6
28. M Makuuchi H Hasegawa S Yamazaki 1985 Ultrasonically guided subsegmentectomy Surg Gynecol Obstet. 161 346 350 2996162 1:STN:280: DyaL28%2FhvFCjtA%3D%3D
29. M Yamamoto K Takasaki T Otsubo, et al. 2004 Favorable surgical outcomes in patients with early hepatocellular carcinoma Ann Surg. 239 395 399 15075658 10.1097/01.sla.0000114215.03112.e0
30. T Itamoto K Katayama H Nakahara H Tashiro T Asahara 2003 Autologous blood storage before hepatectomy for hepatocellular carcinoma with underlying liver disease Br J Surg. 90 23 28 12520570 10.1002/bjs.4012 1:STN:280: DC%2BD3s%2FhtlWlug%3D%3D
31. PA Clavien J Barkun ML de Oliveira, et al. 2009 The Clavien-Dindo classification of surgical complications: five-year experience Ann Surg. 250 187 196 19638912 10.1097/SLA.0b013e3181b13ca2
32. AR Zinsmeister JT Connor 2008 Ten common statistical errors and how to avoid them Am J Gastroenterol. 103 262 266 18289193 10.1111/j.1572-0241.2007. 01590.x
33. PR Rosenbaum DB Rubin 1983 The central role of the propensity score in observational studies for causal effects Biometrika. 70 41 55 10.1093/biomet/70.1.41
34. DB Rubin 1997 Estimating causal effects from large data sets using propensity scores Ann Intern Med. 127 757 763 9382394 1:STN:280: DyaK2svmvVKitQ%3D%3D
35. RB D'Agostino Jr 1998 Propensity score methods for bias reduction in the comparison of a treatment to non-randomized control group Stat Med. 17 2265 2281 9802183 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2- B
36. V Brinkmann T Geiger S Alkan CH Heusser 1993 Interferon alpha increases the frequency of interferon gamma-producing human CD4+T cells J Exp Med. 178 1655 1663 8228812 10.1084/jem.178.5.1655 1:CAS:528:DyaK3sXmtVWmsbo%3D
37. L Wang ZY Tang LX Qin, et al. 2000 High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential Hepatology. 32 43 48 10869287 10.1053/jhep.2000.8525 1:CAS:528:DC%2BD3cXltFWgs74%3D
38. Y Shiratori S Shiina T Teratani, et al. 2003 Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C Ann Intern Med. 138 299 306 12585827